New combo attack on tough tumors aims to save limbs
NCT ID NCT05235100
Summary
This study tested a two-part treatment given before surgery for soft tissue sarcoma in the arms, legs, or trunk. Doctors combined a targeted cancer drug (apatinib) with precise, shaped radiation (IMRT) to try to shrink tumors more effectively. The main goals were to see if this approach was safe, reduced serious wound problems after surgery, and helped preserve patients' limb function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA,SOFT TISSUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.